1. Most Discussed
  2. Gainers & Losers
CMP 38.0¢

Compumedics !!!!!!

  1. ytrade

    1,430 posts.


    --------------------------------------------------------------------------------

    29/07/2002 10:07:42
    Letter of Intent signed with Drager Medical

    COMPUMEDICS LIMITED 2002-07-29 ASX-SIGNAL-G

    HOMEX - Melbourne

    +++++++++++++++++++++++++
    Compumedics Ltd (ASX:CMP) headquartered in Melbourne, Australia, and
    Pre & Post Hospital Care, a division of Drager Medical AG & Co KGaA,
    headquartered in Luebeck, Germany, have signed a letter of intent for
    the supply and development of sleep diagnostic technology.

    Compumedics expects to realize an additional sales revenue of
    approximately AUD$ one million (approx E0.55 million) in the initial
    12-month contract period. Drager Medical will have exclusive sales
    and marketing rights in Germany for Compumedics' Somte(TM)
    cardio-respiratory monitoring units and non-exclusive rights in
    France and Benelux. Both parties have also confirmed their intention
    to cooperate on a broader technological and strategic basis.

    The Somte(TM) system is a first of its kind - a lightweight medical
    recorder that combines features of diagnostic sleep systems and
    cardiac holter recorders. The very small (200 gram) device can be
    used by a patient at home to provide information for early detection
    of cardiac dysfunction. Somte(TM) was released to the European market
    only three months ago after receiving the required European Union CE
    regulatory approval.

    Compumedics Executive Chairman, David Burton said, "To have a partner
    of the international standing of Drager Medical is a significant
    boost for Compumedics. The relationship will not only provide ready
    access to an important part of the European sleep diagnostics market,
    but also give us a technology partner without peer to work with on
    the commercialization of new products."

    The link is important for Compumedics' revamped international
    distribution strategy. "We are now able to work with world class
    companies such as Drager Medical to take Compumedics' sleep
    technology to European customers," David Burton added.

    Dr M Thijs A Teeling, General Manager, Pre & Post Hospital Care,
    Drager Medical said, "The portable Somte(TM) diagnostic system is
    ideally suited for the home health care sector, which has become a
    major area of focus for our business. We are a leader in
    state-of-the-art medical technologies, so adding the supply of sleep
    diagnostic technology to our current product portfolio was a natural
    fit. Finally, we look forward to working with Compumedics to develop
    other products for the European markets."

    The diagnosis and treatment of sleep disorders is a rapidly growing
    field of medicine worldwide. In the United States alone, there are
    already 2400 specialist sleep treatment centres, with the market
    growing at over 10% per annum.

    PRESS CONTACT:

    Compumedics:
    David Burton
    EXECUTIVE CHAIRMAN, CEO
    Phone: +61 3 8413 7300
    Fax: +61 3 8413 7399
    [email protected]

    Drager Medical:
    Bjoern Woelke
    PR MANAGER
    CORPORATE COMMUNICATIONS
    Phone: +49 451 882-2009
    Fax: +49 451 882-3197
    [email protected]


    ABOUT COMPUMEDICS

    For more information, please visit: www.compumedics.com.au

    ABOUT DRAGER MEDICAL

    Drager Medical AG & Co KGaA is one of the world's leading
    manufacturers of medical equipment. As the largest division of
    Dragerwerk AG, Drager Medical offers integrated systems and services
    throughout the entire patient care process in clinical acute care and
    the home care sector. Drager Medical employs approximately 4,800
    people worldwide and is represented in over 100 countries. Over the
    past six years, the company continually boosted its sales by more
    than 10% a year, reaching a total of 805 million Euro in fiscal 2001.
    In the same period, the company quadrupled its EBIT from 9.1 million
    Euro to 39.0 million Euro. The innovative concepts of Drager Medical
    are the result of close dialogue with customers, years of experience
    in the market, and significant investment in R&D. The company's goal
    is to improve the quality of patient care while supporting cost
    reduction in the health care sector.
    For more information, please visit: www.draeger.com.


    Rising from an oversold base of .145

    Good Trading
    Ytrade





DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top